Sign in Sign up for free

Adma Biologics Inc Gross margin

What is the Gross margin of Adma Biologics Inc?

The Gross margin of Adma Biologics Inc is 34.44%

What is the definition of Gross margin?



Gross margin is the difference between revenue and cost of goods sold, divided by revenue, and expressed as a percentage.

lfy (last fiscal year)

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Gross margin of companies in the Health Care sector on NASDAQ compared to Adma Biologics Inc

What does Adma Biologics Inc do?

adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.

Companies with gross margin similar to Adma Biologics Inc